- $1.46bn
- $1.28bn
- $2.80m
Brief: Absci Prices Public Offering At $3.00 Per Share
Brief: ABSCI Announces Proposed Public Offering Of Common Stock
Brief: Absci Corp Files For Common Stock Offering Of Up To $50 Million - SEC Filing
Absci Corp reports results for the quarter ended March 31 - Earnings Summary
Brief: Absci Q1 Revenue USD 1.179 Million
Brief: Absci Announces First Participants Dosed In Phase 1 Clinical Trial Of Abs-101, A Potential Best-In-Class Anti-TL1a Antibody For The Treatment Of Inflammatory Bowel Disease
Absci Corp expected to post a loss of 23 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Wells Fargo, American Express, Mondelez
U.S. STOCKS ON THE MOVE-TreeHouse Foods, Sarepta Therapeutics, Walmart
U.S. STOCKS ON THE MOVE-Morgan Stanley, Fluence Energy, Bank of New York
AI-based drug developers rise on US FDA's plans to replace animal testing
Brief: Absci Corp Files Prospectus To Offer & Resale, From Time To Time, Of Up To 5.7 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Absci Corp reports results for the quarter ended December 31 - Earnings Summary
Absci Corp expected to post a loss of 24 cents a share - Earnings Preview
Brief: Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-SmartFinancial, TE Connectivity, Arista Networks
U.S. STOCKS ON THE MOVE-MP Materials, Seagate, Teledyne
U.S. STOCKS ON THE MOVE-Interactive Brokers, Travelers, LanzaTech
U.S. STOCKS ON THE MOVE-Johnson & Johnson, United Airlines, AI stocks